Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for nonalcoholic steatohepatitis
2008-002325-37Phase 4Active
- Sponsor
- Ruhr University Bochum
- Start
- Aug 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in metabolic dysfunction-associated steatohepatitis (MASH) comparing Exenatide with Placebo (2 arms). Primary endpoint: Absolute change in NASH activity score. Started Aug 2009; status: active.
02
Drugs
exenatide
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on 2008-002325-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002325-37.